Taking Immunotherapy Seriously: New Targets and Combinations

This panel will explore the rapidly evolving immunotherapy space, focusing on the increasing value of combinations such as multiple immunotherapies as well as with chemotherapy and targeted agents. Our exploration of next generation approaches such as new checkpoint targets beyond PD1 and novel cell-based therapies like CAR T-cells will lead to a lively discussion and […]